BioWorld has reported on numerous advances in digital health, which are tantalizing examples of how digitization could transform health care, but it has long been clear lip service repetition of the term "digital health" is not enough to deliver its potential: the first FDA approval of an artificial intelligence system for diagnosing diabetic retinopathy without requiring a clinician to assess an image; the launch of NIH's All of Us program, which aims to propel the development of personalized medicine by making a repository of health data from 1 million Americans available for research; and the arrival of the first true digital therapeutic judged by the FDA to the same clinical evidence standards as are applied to drug approvals.